R. Steven Davidson, Ph.D.,
Dr. Davidson has been the Company's President and Chief Executive Officer since January 2002 and a director since April 2002. Dr. Davidson has over eight years of experience in the biopharmaceutical industry. From September 1998 to December 2001, Dr. Davidson was the chief executive officer and a director of Gel Tech, LLC. At Gel Tech, Dr. Davidson raised capital for the market launch and distribution of the Zicam cold remedy. He led the marketing team that took Zicam from an unknown entity to one of the top medications in its class. He also implemented and launched line extensions to strengthen brand name and increase company value. During this period, Dr. Davidson was also the managing director of Biodelivery Technologies, Inc. From October 1994 to August 1998, Dr. Davidson was the chief executive officer of Biotem Cytotechnologies, Inc., a biopharmaceutical research and development company. Dr. Davidson received his MBA in International Finance and Ph.D. in Biopharmaceutical Project Management from the American University of Asturias, Spain and performed post graduate studies at Villanova University.